(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

'Pharmaceutical' published the research on the efficiency of exsome-based DDS* by Dr. Ahn of ILIAS Biologics, Inc.

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 21-04-14 09:35
  • 조회 : 122회

본문

 

22 March 2021


'Pharmaceutical' published the research on the efficiency of exsome-based DDS* by Dr. Ahn of ILIAS Biologics, Inc.  

 

March 22nd issue of ‘Pharmaceutics’ published the research titled 'Biodistribution and pharmacokinectics of liposomes and exosomes in a mouse model of sepsis.’ by Dr. Ji-Ho Park, professor at KAIST and Dr. So-Hee Ahn, principal scientist leading Analytics Development Team at ILIAS Biologics, Inc.

Please find the publication at the link below.

*DDS: Drug Delivery System

 

Publication (Link)

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기